Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
暂无分享,去创建一个
Eric E. Smith | M. E. Kooi | S. F. Tsang | E. Vicaut | M. Hennerici | A. Algra | P. Maeder | M. Power | A. Leff | P. Nachev | D. Werring | A. Gass | P. Rothwell | F.‐E. Leeuw | E. Hui | N. Venketasubramanian | F. Fazekas | V. Mok | H. Mak | K. Chan | B. Gómez-Anson | J. Hendrikse | D. Calvet | H. Jäger | V. Srikanth | P. Nederkoorn | R. Marsh | T. Yousry | W. Chu | P. Koudstaal | H. Chabriat | J. Wardlaw | C. Pachai | N. Bornstein | A. Lugt | L. Kappelle | A. Charidimou | R. Bordet | A. Korczyn | M. Dennis | J. Staals | C. Delmaire | P. Armitage | S. Thilemann | F. Chappell | R. Delgado-Mederos | J. Martí-Fàbregas | M. Thrippleton | Mark White | W. Mess | K. Harkness | V. Thijs | J. Ly | T. Phan | S. Engelter | S. Köhler | K. Muir | A. Parry-Jones | Jae-Sung Lim | H. Houlden | E. Jouvent | Simon Jung | E. Arsava | H. Ay | R. Salman | A. Tuladhar | J. O'connell | H. Mattle | K. Lau | G. Ambler | N. Kandiah | J. Abrigo | A. Wong | S. Hilal | N. Maaijwee | M. Douste-Blazy | M. Brown | G. Lip | P. Kelly | S. Sato | R. Perry | R. Simister | M. Koga | K. Lee | B. Kim | H. Bae | K. Toyoda | Wenyan Liu | S. Muñoz-Maniega | S. Coutts | R. Cheung | Y. Roos | Pankaj Sharma | M. El-Koussy | U. Fischer | Young Dae Kim | J. Heo | J. Purrucker | E. Kliper | J. Thornton | L. Bonati | J. Mas | Henry Ma | M. Lou | D. Mangion | N. Sprigg | G. Banerjee | P. Ng | R. Chandra | R. Lemmens | Christopher Chen | L. Slater | R. Veltkamp | S. Bakker | Bibek Gyanwali | B. Lam | S. Makin | N. Peters | Y. Soo | T. Leung | Elles Douven | S. Ma | A. Heye | E. Sakka | A. Mendyk | P. Brouwers | P. Lyrer | T. Imaizumi | J. Stam | J. Best | J. Birns | R. Chang | K. Yoshifuji | Ahamad Hassan | M. Schembri | Carmen Barbato | M. Mamun | Enas Lawrence | D. Manawadu | C. Roffe | W. Fong | F. Fluri | K. Wiegertjes | Duncan Wilson | David J. Williams | H. Hallevi | H. Gensicke | Y. Yakushiji | V. Kwa | S. Murphy | M. Randall | K. Miwa | Jihoon Kang | Moon‐Ku Han | E. Flossmann | D. Hargroves | D. Cohen | E. Warburton | H. Emsley | Tae-Jin Song | Linxin Li | C. Zerna | Ying Zhou | D. Seiffge | Kari Saastamoinen | H. Hara | L. Prats-Sánchez | A. Martínez-Domeño | P. Camps-Renom | R. Marín | K. Dani | S. Medrano-Martorell | E. Merino | M. Hernández | S. Horstmann | M. Nishihara | S. Inamura | C. Lovelock | D. N. Orken | E. Uysal | J. Tanaka | T. Ide | T. Gattringer | D. Guisado-Alonso | M. Shiozawa | Y. Wong | S. Eppinger | Z. Tanrıverdi | E. B. Assayag | A. Polymeris | L. Panos | L. Legrand | C. Karayiannis | Sarah Gunkel | Nicolas Christ | D. Hayden | Simone Browning | C. Yatawara | Chao Xu | L. Shaw | J. Sword | Deborah Kelly | F. Harrington | Matthew Smith | K. Mahawish | Abduelbaset Elmarim | B. Esisi | C. Cullen | Arumug Nallasivam | C. Price | A. Barry | J. Coyle | L. Sekaran | A. Parry | Harald Proschel | Prabel Datta | K. Darawil | A. Manoj | M. Burn | C. Patterson | E. Giallombardo | N. Smyth | S. Mansoor | Ijaz Anwar | S. Ispoglou | D. Chadha | M. Prabhakaran | Sanjeevikumar Meenakishundaram | Jon F Scott | Vinodh Krishnamurthy | Prasanna Aghoram | M. Mccormick | P. O'mahony | M. Cooper | Lillian Choy | P. Wilkinson | S. Leach | Sarah Caine | I. Burger | G. Gunathilagan | P. Guyler | Michelle L. Davis | Kath Pasco | R. Luder | M. Sajid | J. Okwera | T. England | Janet Putterill | E. Flossman | A. Suman | J. Corrigan | D. Vahidassr | C. Shakeshaft | P. Gratz | J. Molad | Luc Bracoub | M. Fratacci | K. Fujita | C. Soufan | C. Moran | C. Traenka | J. Fladt | E. Ko | M. Yang | M. Jang | F. Carty | L. Akijian | F. Núñez | Kotaro Iida | S. Ikeda | D. S. Demirelli | Jayesh Modi Medanta | Ysoline Beigneux | Mauro Silva | S. Ho | K. Teo | J. Kwan | M. Tse | C. Hoi | Chung Yan Chan | O. L. Chan | R. Cheung | Edmund Ka Ming Wong | K. Leung | H. Ip | K. Ma | Siu Hung Li | Richard Li | K. K. Wong | Lino Ramos | J. Jöbsis | H. Verbiest | W. Schoonewille | Cisca Linn | L. Hertzberger | P. Berntsen | Nicholas Ward | Hatice Ozkan | John Mitchell | A. M. Nor | S. Singhal | B. Wagner | A. Guevarra | R. V. Oostenbrugge | Hannah Cohen | Hiroyuki Irie | L. Wong | E. D. Schryver | Jaap van der Sande | M. V. Gemert | Dianne H.K. van Dam-Nolen | E. Wong | Appu Suman | Susana Muñoz-Maniega | Ryan Hoi Kit Cheung | S. Browning | Anthea Parry | B. Gyanwali | D. Wilson | Shoichiro Sato | D. Kelly | J. O’Connell | Y. Beigneux | E. Assayag | Y. Kim | María Hernández | K. Wong | M. Kooi | C. Chen | Kim Wiegertjes | Martin M. Brown
[1] Eric E. Smith,et al. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies , 2019, The Lancet Neurology.
[2] R. Delgado-Mederos,et al. MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation. , 2019, Neurology.
[3] E. Antman,et al. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48 , 2019, Circulation.
[4] S. F. Tsang,et al. Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-Warfarin study , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] G. Sanders,et al. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review , 2018, Thrombosis and Haemostasis.
[6] K. Kario,et al. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study. , 2018, Circulation journal : official journal of the Japanese Circulation Society.
[7] M. Power,et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study , 2018, The Lancet Neurology.
[8] S. Gutnikov,et al. Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review , 2018, Stroke.
[9] S. F. Tsang,et al. Correlation of non-vitamin K antagonist oral anticoagulant exposure and cerebral microbleeds in Chinese patients with atrial fibrillation , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[10] G. Lip,et al. Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. , 2018, International journal of cardiology.
[11] A. Algra,et al. External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients , 2018, Stroke.
[12] D. Norris,et al. Nonlinear temporal dynamics of cerebral small vessel disease , 2017, Neurology.
[13] R. Sacco,et al. Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets , 2017, Neurology.
[14] L. Shao,et al. The use of susceptibility-weighted imaging to detect cerebral microbleeds after lacunar infarction. , 2017, European review for medical and pharmacological sciences.
[15] J. Wardlaw,et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.
[16] K. Hong,et al. Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation. , 2017, International journal of cardiology.
[17] R. Sacco,et al. The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment , 2017, Cerebrovascular Diseases.
[18] Klaus P. Ebmeier,et al. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research , 2016, Alzheimer's & Dementia.
[19] S. Yusuf,et al. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation , 2016, Circulation.
[20] V. Srikanth,et al. Prevalence of Brain MRI Markers of Hemorrhagic Risk in Patients with Stroke and Atrial Fibrillation , 2016, Front. Neurol..
[21] Eric E. Smith,et al. Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting With Minor Cerebrovascular Events , 2016, Stroke.
[22] S. Yusuf,et al. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study , 2016, The Lancet.
[23] G. Lip,et al. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. , 2016, The American journal of medicine.
[24] F. Verhey,et al. The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design , 2016, BMC Neurology.
[25] A. Algra,et al. Prediction models for intracranial hemorrhage or major bleeding in patients on antiplatelet therapy: a systematic review and external validation study , 2016, Journal of thrombosis and haemostasis : JTH.
[26] E. Dolan,et al. Rates, Predictors, and Outcomes of Early and Late Recurrence After Stroke: The North Dublin Population Stroke Study , 2016, Stroke.
[27] Frank E. Harrell,et al. Prediction models need appropriate internal, internal-external, and external validation. , 2016, Journal of clinical epidemiology.
[28] M. Möhlenbruch,et al. Prevalence of atrial fibrillation and association of previous antithrombotic treatment in patients with cerebral microbleeds , 2015, European journal of neurology.
[29] P Aspelin,et al. SWI or T2*: Which MRI Sequence to Use in the Detection of Cerebral Microbleeds? The Karolinska Imaging Dementia Study , 2015, American Journal of Neuroradiology.
[30] D. Liebeskind,et al. Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[31] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[32] V. Mok,et al. Risk factors for incident dementia after stroke and transient ischemic attack , 2015, Alzheimer's & Dementia.
[33] Jinkwon Kim,et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation , 2014, Neurology.
[34] A F W van der Steen,et al. Plaque at RISK (PARISK): Prospective Multicenter Study to Improve Diagnosis of High-Risk Carotid Plaques , 2014, International journal of stroke : official journal of the International Stroke Society.
[35] T. Imaizumi,et al. The severities of white matter lesions possibly influence the recurrences of several stroke types. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[36] G. Schroth,et al. Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients , 2014, Stroke.
[37] D. Werring,et al. Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging , 2014, Expert Review of Neurotherapeutics.
[38] M. Wasay,et al. Stroke in Asia: geographical variations and temporal trends , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[39] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.
[40] M. L. Lauzon,et al. Susceptibility-Weighted Imaging is More Reliable Than T2*-Weighted Gradient-Recalled Echo MRI for Detecting Microbleeds , 2013, Stroke.
[41] P. Maeder,et al. Results of the PERFORM magnetic resonance imaging study , 2013, Journal of Neurology.
[42] H. Forta,et al. New cerebral microbleeds in ischemic stroke patients on warfarin treatment: Two-year follow-up , 2013, Clinical Neurology and Neurosurgery.
[43] A. Algra,et al. Microbleeds as a predictor of intracerebral haemorrhage and ischaemic stroke after a TIA or minor ischaemic stroke: a cohort study , 2013, BMJ Open.
[44] G. Wang,et al. Comparison of ESWAN, SWI-SPGR, and 2D T2*-Weighted GRE Sequence for Depicting Cerebral Microbleeds , 2013, Clinical Neuroradiology.
[45] Mårten Rosenqvist,et al. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. , 2012, European heart journal.
[46] T. Hendler,et al. Predictors for Poststroke Outcomes: The Tel Aviv Brain Acute Stroke Cohort (TABASCO) Study Protocol , 2012, International journal of stroke : official journal of the International Stroke Society.
[47] F. Hatz,et al. Significance of microbleeds in patients with transient ischaemic attack , 2012, European journal of neurology.
[48] Frederik Barkhof,et al. Clinical Relevance of Improved Microbleed Detection by Susceptibility-Weighted Magnetic Resonance Imaging , 2011, Stroke.
[49] C. Begg,et al. One statistical test is sufficient for assessing new predictive markers , 2011, BMC Medical Research Methodology.
[50] P. van Damme,et al. Microbleeds and the Risk of Recurrent Stroke , 2010, Stroke.
[51] Ale Algra,et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis , 2010, The Lancet Neurology.
[52] D. Werring,et al. The Microbleed Anatomical Rating Scale (MARS) , 2009, Neurology.
[53] Eric E. Smith,et al. MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength , 2008, American Journal of Neuroradiology.
[54] Hidenao Fukuyama,et al. Microbleeds in Moyamoya Disease: Susceptibility-Weighted Imaging Versus T2*-Weighted Imaging at 3 Tesla , 2008, Investigative radiology.
[55] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[56] Patrick Royston,et al. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer , 2004, Statistics in medicine.
[57] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[58] J. Habbema,et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.
[59] R L Williams,et al. A Note on Robust Variance Estimation for Cluster‐Correlated Data , 2000, Biometrics.